PDB94 - INITIAL ANTIDIABETIC PHARMACOTHERAPY PRESCRIBED TO PATIENTS WITH NEWLY DIAGNOSED TYPE-2 DIABETES IN A COMMERCIAL HEALTH PLAN IN THE UNITED STATED

Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.799
https://www.valueinhealthjournal.com/article/S1098-3015(18)34099-3/fulltext
Section Title :
Section Order : 198
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34099-3&doi=10.1016/j.jval.2018.09.799
HEOR Topics :
Tags :
Regions :